ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1307

Plasma levels of monounsaturated fatty acids (MUFAs) positively correlate with disease activity in patients with rheumatoid arthritis (RA)

Martha Belury1, Rachel Cole1, Steven Pan2 and Beatriz Hanaoka2, 1Ohio State University, Columbus, OH, 2Oklahoma University Health Sciences Center, Oklahoma City, OK

Meeting: ACR Convergence 2025

Keywords: rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1306–1346) Rheumatoid Arthritis – Diagnosis, Manifestations, and Outcomes Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) patients have higher body fat percentages, particularly in the abdominal region, which is associated with increased systemic inflammation. Obesity is associated with changes in plasma fatty acid composition, which can affect inflammatory responses. Omega-3 polyunsaturated fatty acids (n3-PUFA) are precursors for anti-inflammatory oxylipins while the roles of n6 PUFAs and monounsaturated fatty acids (MUFAs) remain less well understood. The goal of this study was to investigate FFA composition of plasma of patients with RA and its associations with RA disease activity.

Methods: Cross-sectional study involving 52 RA patients and 30 age-, sex-, and BMI-matched non-RA controls. Participants were evaluated for body mass index (BMI), healthy eating index (HEI), and lipid plasma fatty acid composition after an overnight fast. RA disease activity was assessed using the Clinical Disease Activity Index (CDAI). The correlation between plasma FFAs and CDAI was examined using univariate, Spearman correlation and multivariate linear regression analyses.

Results: Among RA subjects, plasma levels of MUFAs [palmitoleic acid (p=0.022), oleic acid (p=0.001), and gondoic acid (p=0.048)] were higher compared to controls. In contrast, plasma levels of n6 PUFAs [linoleic acid (p=0.031) and arachidonic acid (0.004)] were higher in controls compared to RA patients. Oleic acid (r = 0.349, p = 0.013) and gondoic acid (r = 0.435, p = 0.002) showed significant correlations with CDAI. Correlation analyses showed oleic acid (r = 0.349, p = 0.013) and gondoic acid (r = 0.435, p = 0.002) significantly correlated with CDAI. Multivariate linear regression analyses revealed CDAI was independently associated with oleic acid (β = 0.09, 95% CI = 0.02-0.16, p = 0.014) and gondoic acid (β = 0.0012, 95% CI = 0.0005-0.0020, p = 0.002), after adjusting for age, sex, BMI, and HEI.

Conclusion: The findings suggest a potential association between elevated plasma MUFAs and disease activity in patients with RA.


Disclosures: M. Belury: None; R. Cole: None; S. Pan: None; B. Hanaoka: None.

To cite this abstract in AMA style:

Belury M, Cole R, Pan S, Hanaoka B. Plasma levels of monounsaturated fatty acids (MUFAs) positively correlate with disease activity in patients with rheumatoid arthritis (RA) [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/plasma-levels-of-monounsaturated-fatty-acids-mufas-positively-correlate-with-disease-activity-in-patients-with-rheumatoid-arthritis-ra/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/plasma-levels-of-monounsaturated-fatty-acids-mufas-positively-correlate-with-disease-activity-in-patients-with-rheumatoid-arthritis-ra/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology